Cited by 154Alzheimer's disease research and treatmentsPrion Diseases and Protein MisfoldingAmyloidosis: Diagnosis, Treatment, Outcomes

Furin mediates enhanced production of fibrillogenic ABri peptides in familial British dementia

Kim, Seong-Hun, Wang, Rong, Gordon, David J., Bass, Joseph, Steiner, Donald F., Lynn, David G., Thinakaran, Gopal, Meredith, Stephen C. +1 more·1999·Nature Neuroscience

Abstract

The genetic lesion underlying familial British dementia (FBD), an autosomal dominant neurodegenerative disorder, is a T-A transversion at the termination codon of the BRI gene. The mutant gene encodes BRI-L, the precursor of ABri peptides that accumulate in amyloid deposits in FBD brain. We now report that both BRI-L and its wild-type counterpart, BRI, were constitutively processed by the proprotein convertase, furin, resulting in the secretion of carboxyl-terminal peptides that encompass all or part of ABri. Elevated levels of peptides were generated from the mutant BRI precursor. Electron microscopic studies revealed that synthetic ABri peptides assembled into irregular, short fibrils. Collectively, our results support the view that enhanced furin-mediated processing of mutant BRI generates fibrillogenic peptides that initiate the pathogenesis of FBD.

Integrity signals

Registry

Crossref · 10.1038/14783

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • BRI2 is expressed at high levels in the brain.

    “It is expressed at high levels in the brain and cleaved by furin or furin-like proteases at its C terminus to produce a 23 aa peptide (Bri2-23) (Kim et al., 1999;Choi et al., 2004) (Fig. 1 B).”

    From BRI2 (ITM2b) Inhibits A  Deposition In Vivo (2008) · cites this paper as Kim et al., 1999

  • The 23 aa peptide Bri23 is released from BRI2 by normal processing.

    “It is expressed at high levels in the brain and cleaved by furin or furin-like proteases at its C terminus to produce a 23 aa peptide (Bri2-23) (Kim et al., 1999;Choi et al., 2004) (Fig. 1 B).”

    From BRI2 (ITM2b) Inhibits A  Deposition In Vivo (2008) · cites this paper as Kim et al., 1999

The citation lists haven’t been fetched yet

References 25 · Cited by 154

Authors
Kim, S.-H., Wang, R., Gordon, D. J., Bass, J., Steiner, D. F., Lynn, D. G., Thinakaran, G., Meredith, S. C., & Sisodia, S. S.
Affiliations
  • University of Chicago (US)
  • Rockefeller University (US)
  • Howard Hughes Medical Institute (US)
Corresponding author
Sisodia, Sangram S.
Venue
Nature Neuroscience
Published
1999-11
Volume
2
Issue
11
Pages
984-988
ISSN
  • 1097-6256 (ISSN-L)
  • 1546-1726
OpenAlex
W1536159446
Cited by
154
References
25
Citations by year
2025: 5 · 2024: 5 · 2023: 4 · 2022: 5 · 2021: 3 · 2020: 3 · 2018: 4 · 2017: 2 · 2016: 4 · 2015: 9 · 2014: 5 · 2013: 4 · 2012: 3
FWCI
6.42
Type
journal article
Language
en
Open access
closed
Locations
  • Nature Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute on Aging (AG 14248, P01AG014248)
  • National Institute of General Medical Sciences (5T32 GM-07281, T32GM007281)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Amyloidosis: Diagnosis, Treatment, Outcomes
Keywords
furin, familial British dementia, amyloid-beta, proprotein convertases, protein processing, amyloid fibrils, amyloid deposition, neurodegeneration
MeSH terms
Amyloid, Animals, Dementia, United Kingdom, Membrane Glycoproteins, Membrane Proteins, Microscopy, Electron, Neurofibrils, Peptide Fragments, Subtilisins, Tumor Cells, Cultured, Heredodegenerative Disorders, Nervous System, Furin, Adaptor Proteins, Signal Transducing, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review